Equities

Diaceutics PLC

DXRX:LSE

Diaceutics PLC

Health CareHealth Care Providers
  • Price (GBX)117.50
  • Today's Change0.00 / 0.00%
  • Shares traded15.10k
  • 1 Year change32.02%
  • Beta0.5450
Data delayed at least 20 minutes, as of Nov 22 2024 16:37 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Diaceutics PLC is a United Kingdom-based technology and solutions provider to pharma and biotech companies. It is engaged in research and development activities in the area of drug development science, precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions and Scientific & Advisory Services. Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.

  • Revenue in GBP (TTM)26.10m
  • Net income in GBP-2.85m
  • Incorporated2005
  • Employees184.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Synectics PLC53.55m3.02m55.70m269.0055.70m269.00
Carillion plc4.41bn-1.07bn60.88m31.63k60.88m31.63k
Anexo Group PLC140.30m9.46m86.13m963.0086.13m963.00
Knights Group Holdings PLC149.96m9.85m93.54m1.43k93.54m1.43k
Diaceutics PLC26.10m-2.85m99.55m184.0099.55m184.00
Spectra Systems Corp24.95m5.23m124.60m--124.60m--
Begbies Traynor Group plc136.73m1.45m145.30m1.25k145.30m1.25k
Data as of Nov 22 2024. Currency figures normalised to Diaceutics PLC's reporting currency: UK Pound GBX

Institutional shareholders

40.71%Per cent of shares held by top holders
HolderShares% Held
Canaccord Genuity Wealth Ltd.as of 31 Dec 20237.75m9.14%
Gresham House Asset Management Ltd. (Investment Management)as of 31 May 20245.70m6.73%
Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 26 Sep 20234.01m4.73%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 20233.63m4.29%
Danske Bank A/S (Investment Management)as of 31 Oct 20243.33m3.93%
Herald Investment Management Ltd.as of 31 Dec 20203.01m3.55%
BlackRock Investment Management (UK) Ltd.as of 14 Nov 20242.71m3.20%
Handelsbanken Fonder ABas of 31 Oct 20241.52m1.79%
EdenTree Investment Management Ltd.as of 01 Oct 20241.43m1.69%
River Global Investors LLPas of 01 Oct 20241.40m1.65%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.